Aktiesnakken — Juni 2010
-
og alt andet lige - alt andet lige - vil det gøre genmab til et takeovermål
-
jeg tror ikke kun der vil være en der er interesseret i Genmab
-
konkurrenten, roche og alle andre i onkology
-
ja der er masser af triggere i aktien p.t.
-
ja vi tales god weekend
-
AKA.....jeg glæder mig til at være en af de syv du tager med til middagen http://www.hegnar.no/okonomi/article431448.ece
-
-
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind